» Articles » PMID: 33337528

[Diagnostics of Irreversible Brain Death : Limitations and Potential for Improvement from the Perspective of Transplantation Officials]

Overview
Journal Anaesthesist
Specialty Anesthesiology
Date 2020 Dec 18
PMID 33337528
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In Germany, postmortem organ donation requires a diagnosis of irreversible brain death (BD) in strict compliance with the guidelines of the German Medical Association.

Objective: Identification of factors that have a limiting effect on the initiation and execution of BD diagnostics. Identification of potential for improvement.

Material And Methods: Anonymous survey of transplantation officials in hospitals in Berlin, Brandenburg and Mecklenburg-Western Pomerania.

Results: There is considerable heterogeneity with respect to the frequency of BD diagnostics and hospital-specific procedures, including the use of an existing consultation service. The local availability of qualified doctors and of suitable ancillary diagnostic tests has a structurally limiting effect. This is especially true for pediatric patients. Potential for improvement was seen in the identification of affected patients, the motivation of staff and the role of transplantation officials.

Conclusion: According to the recently amended German Transplantation Act, a centrally organized consultation service for BD diagnostics must be implemented as soon as 2021. Recommendations can be derived from the present survey and from the experience of the regionally established consultation service. In addition to neurological and neurosurgical expertise, qualified pediatricians and mobile ancillary instrumental diagnostics should also be provided. Expert advice from neurointensive care physicians should be available at an early stage in order to identify potentially affected patients. The highly variable participation of hospitals in organ donation, despite the availability of an expert diagnostic service free of charge, points to an important role of additional factors, some of which may be nonmedical in nature.

Citing Articles

[Diagnosis of brain death in Germany-Implementation of the guidelines of the German Medical Association].

Hoffmann O, Salih F, Masuhr F Nervenarzt. 2023; 94(12):1129-1138.

PMID: 37462719 PMC: 10684634. DOI: 10.1007/s00115-023-01520-5.

References
1.
Braun F, Rahmel A . [Amendments to the Transplantation Act and impact on the donor situation in Germany]. Chirurg. 2020; 91(11):905-912. PMC: 7379752. DOI: 10.1007/s00104-020-01242-3. View

2.
Brauer M, Gunther A, Pleul K, Gotze M, Wachsmuth C, Meinig T . [How many potential organ donors are there really? : Retrospective analysis of why determination of irreversible loss of brain function was not performed in deceased patients with relevant brain damage]. Anaesthesist. 2018; 68(1):22-29. DOI: 10.1007/s00101-018-0510-x. View

3.
Hoffmann O, Masuhr F . Use of Observational Periods or Ancillary Tests in the Determination of Brain Death in Germany. Eur Neurol. 2015; 74(1-2):11-7. DOI: 10.1159/000431089. View

4.
Hoffmann O, Masuhr F . [Access to brain death diagnostics]. Nervenarzt. 2014; 85(12):1573-81. DOI: 10.1007/s00115-014-4171-y. View

5.
Janssens U, Burchardi H, Duttge G, Erchinger R, Gretenkort P, Mohr M . [Change in therapy target and therapy limitations in intensive care medicine. Position paper of the Ethics Section of the German Interdisciplinary Association for Intensive Care and Emergency Medicine]. Anaesthesist. 2013; 62(1):47-52. DOI: 10.1007/s00101-012-2126-x. View